- Home
- NEU vs ROIV Comparison
NEU vs ROIV Comparison
Compare NEU & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEU
- ROIV
- Stock Information
- Founded
- NEU 1887
- ROIV 2014
- Country
- NEU United States
- ROIV United Kingdom
- Employees
- NEU N/A
- ROIV N/A
- Industry
- NEU Major Chemicals
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- NEU Industrials
- ROIV Health Care
- Exchange
- NEU Nasdaq
- ROIV Nasdaq
- Market Cap
- NEU 7.9B
- ROIV 8.6B
- IPO Year
- NEU N/A
- ROIV N/A
- Fundamental
- Price
- NEU $854.03
- ROIV $16.14
- Analyst Decision
- NEU
- ROIV Strong Buy
- Analyst Count
- NEU 0
- ROIV 8
- Target Price
- NEU N/A
- ROIV $19.94
- AVG Volume (30 Days)
- NEU 91.4K
- ROIV 9.5M
- Earning Date
- NEU 10-30-2025
- ROIV 11-11-2025
- Dividend Yield
- NEU 1.28%
- ROIV N/A
- EPS Growth
- NEU 17.77
- ROIV N/A
- EPS
- NEU 50.47
- ROIV N/A
- Revenue
- NEU $2,779,049,000.00
- ROIV $23,233,000.00
- Revenue This Year
- NEU N/A
- ROIV N/A
- Revenue Next Year
- NEU N/A
- ROIV $248.22
- P/E Ratio
- NEU $17.05
- ROIV N/A
- Revenue Growth
- NEU 2.27
- ROIV N/A
- 52 Week Low
- NEU $480.00
- ROIV $8.73
- 52 Week High
- NEU $867.78
- ROIV $16.79
- Technical
- Relative Strength Index (RSI)
- NEU 66.37
- ROIV 77.88
- Support Level
- NEU $826.65
- ROIV $14.86
- Resistance Level
- NEU $867.78
- ROIV $16.79
- Average True Range (ATR)
- NEU 14.98
- ROIV 0.47
- MACD
- NEU 0.56
- ROIV 0.05
- Stochastic Oscillator
- NEU 80.05
- ROIV 72.27
About NEU NewMarket Corp
NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives. Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It comprises two broad product applications. Lubricant additives are formulated chemical solutions that, when blended with base fluids, improve the efficiency, durability, performance, and functionality of mineral oils, synthetic oils, and biodegradable fluids. Fuel additives are chemical components that help oil refiners meet fuel specifications or formulated packages that improve the performance of gasoline, diesel, biofuels, and other fuels.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.